Physical symptoms and emotional responses among women undergoing induced abortion protocols during the second trimester
- PMID: 27539053
- DOI: 10.1016/j.ijgo.2016.05.008
Physical symptoms and emotional responses among women undergoing induced abortion protocols during the second trimester
Abstract
Objective: To compare the physical and emotional effects of two medical protocols for induced abortion during the second trimester.
Methods: The present study was part of a prospective randomized controlled trial comparing mifepristone followed by oxytocin or misoprostol that was conducted at the Hadassah Hebrew University Medical Center, Jerusalem, Israel, from January 10, 2009, to February 22, 2012. Inclusion criteria were pregnancy (14-24weeks), epidural analgesia, and medical induction of abortion (either elective or following missed abortion). A structured questionnaire was used to assess the participants' physical symptoms and emotional responses. The primary outcome for the present analysis was the degree of physical symptoms reported.
Results: Overall, 68 women in the oxytocin group and 67 in the misoprostol group received epidural analgesia and completed the questionnaire. As assessed using a five-point Likert scale, women in the misoprostol group were more likely than those in the oxytocin group to experience diarrhea (1.34±0.84 vs 1.10±0.55; P=0.05) and shivers (3.03±1.75 vs 1.75±1.21; P<0.001). No other between-group differences were detected for the physical or emotional variables evaluated.
Conclusion: Differences in physical symptoms experienced by the two treatment groups did not influence the participants' subsequent emotional response. ClinicalTrials.gov: NCT00784797.
Keywords: Emotions; Induced abortion; Mifepristone; Misoprostol; Oxytocin; Second trimester.
Copyright © 2016 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.Contraception. 2007 Mar;75(3):230-7. doi: 10.1016/j.contraception.2006.11.007. Epub 2007 Jan 16. Contraception. 2007. PMID: 17303495 Clinical Trial.
-
Randomized study on the effect of adding oxytocin to ethacridine lactate or misoprostol for second-trimester termination of pregnancy.Acta Obstet Gynecol Scand. 2006;85(7):825-9. doi: 10.1080/00016340500345337. Acta Obstet Gynecol Scand. 2006. PMID: 16817081 Clinical Trial.
-
Dosing interval of 24hours versus 48hours between mifepristone and misoprostol administration for mid-trimester termination of pregnancy.Int J Gynaecol Obstet. 2014 Feb;124(2):134-8. doi: 10.1016/j.ijgo.2013.08.009. Epub 2013 Oct 31. Int J Gynaecol Obstet. 2014. PMID: 24262683 Clinical Trial.
-
The mifepristone-misoprostol regimen for early medical abortion.Curr Womens Health Rep. 2001 Dec;1(3):184-90. Curr Womens Health Rep. 2001. PMID: 12112968 Review.
-
Medical and surgical options for induced abortion in first trimester.Best Pract Res Clin Obstet Gynaecol. 2010 Aug;24(4):503-16. doi: 10.1016/j.bpobgyn.2010.02.006. Epub 2010 Apr 24. Best Pract Res Clin Obstet Gynaecol. 2010. PMID: 20418168 Review.
Cited by
-
Methods for managing miscarriage: a network meta-analysis.Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD012602. doi: 10.1002/14651858.CD012602.pub2. Cochrane Database Syst Rev. 2021. PMID: 34061352 Free PMC article.
-
Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD002253. doi: 10.1002/14651858.CD002253.pub4. Cochrane Database Syst Rev. 2019. PMID: 31206170 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials